Radiopharmacy in Africa: perspective of Ethiopia and Kenya

Alemu, Ashalew and Mushira, Joel Munene and Wanjeh, David Mwanza and Janevik-Ivanovska, Emilija (2015) Radiopharmacy in Africa: perspective of Ethiopia and Kenya. In: 11th Asia Oceania Congress of Nuclear Medicine and Biology; 54th Annual Autumn Meeting of the Korean Society of Nuclear Medicine; 14th Annual General Meeting of Asian Regional Cooperative Council for Nuclear Medicine, 31 Oct - 04 Nov 2015, Jeju, South Korea.

This is the latest version of this item.

[img]
Preview
Text
A.Alemu - AOJNMB.pdf

Download (180Kb) | Preview
[img]
Preview
Image
AOJNMB - Vol. 3 supplement 1 2015 front page.pdf

Download (66Kb) | Preview
[img]
Preview
Text
AOJNMB - Vol. 3 supplement 1 2015.pdf

Download (4015Kb) | Preview
[img]
Preview
Text
RADIOPHARMACY IN AFRICA PERSPECTIVEOF ETHIOPIA AND KENYA.pdf

Download (518Kb) | Preview
Official URL: http://aojnmb.mums.ac.ir/volume_576.html

Abstract

Objectives: The article seeks to describe the current status of Radiopharmacy practice in Eastern Africa using the perspective of Kenya and Ethiopia. Methods: Non-communicable diseases (NCDs) are a challenge of epidemic proportion and that they will be the commonest cause of mortality in Africa by 2030. Since early detection and treatment is known to significantly improve patient outcomes, radiopharmaceuticals have become of invaluable benefit because they offer the most sensitive tools in the detection, diagnosis and targeted therapy of NCDs and also infectious diseases. In light of the foregoing, therefore, radiopharmacy has a huge role to play in responding to the unfolding new disease trends in sub-Saharan Africa. Results: The preparation of radiopharmaceuticals for human use requires that it is carried out in welldefined and controlled conditions to avoid the risk contamination with microbes, pyrogens and particulate matter as well as cross contamination with other radiopharmaceuticals. Accordingly, principles of Good Manufacturing Practices and Good Laboratory Practices should strictly be observed in the production, preparation, testing and the packaging of the final product ready for use. Most radiopharmaceuticals are parenterally administered and must therefore be prepared in such condition, and using such techniques and procedure, that guarantee sterility of the product. Every procedure undertaken should be done according to the clearly defined protocol and under the right conditions so as to build quality into the product. Radiopharmacy professionals should have adequate training in all aspects of sterile production, quality control, GMP , GLP, radiation safety and radiochemistry to ensure that they are competent to handle radioactive materials and that they can take responsibility for their level of practice Conclusions: The exact information on the number and status of radiopharmacy units, regionally, is still not clearly documented. Important information for the Eastern Africa region that also needs to be documented includes issues of human resource and local demand for the radiopharmacy services. It is the existence of this gap that necessitated the preparation of this article.

Item Type: Conference or Workshop Item (Poster)
Subjects: Medical and Health Sciences > Other medical sciences
Divisions: Faculty of Medical Science
Depositing User: Emilija Janevik
Date Deposited: 11 Feb 2016 10:19
Last Modified: 11 Feb 2016 10:19
URI: http://eprints.ugd.edu.mk/id/eprint/15375

Available Versions of this Item

Actions (login required)

View Item View Item